Novocure Ltd Ord Sh (NVCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCR | ANAB | URGN | ||
| Company | Novocure Ltd Ord Sh | Anaptysbio Inc | Urogen Pharma Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.33 | 58.95 | 33.96 | ||
| High | 14.51 | 60.04 | 35.35 | ||
| Low | 13.51 | 57.54 | 33.69 | ||
| Latest | 13.61 | 59.99 | 34.99 | ||
| Change | -0.67 | +2.48 | +1.42 | ||
| % Change | -4.69% | +4.31% | +4.23% | ||
| Volume | 1,956,600 | 407,200 | 643,400 | ||
| 20-Day Average Volume | 1,695,780 | 561,700 | 636,175 | ||
| Previous Close | 14.28 | 57.51 | 33.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 16.91 | 55.12 | 29.30 | ||
| 20-Day Raw Stochastic | 1.94% | 81.93% | 96.15% | ||
| 20-Day Relative Strength | 39.76 | 57.31 | 71.66 | ||
| Weighted Alpha | -25.85 | +230.47 | +143.04 | ||
| Today's Opinion | 40% Buy | 72% Buy | 100% Buy | ||
| Previous Opinion | 64% Buy | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -23.45% since 06/12/26 | +6.99% since 06/12/26 | +17.73% since 06/12/26 | ||
| Low | 13.51 on 06/22/26 | 55.16 on 06/18/26 | 29.46 on 06/15/26 | ||
| High | 18.35 on 06/15/26 | 60.49 on 06/16/26 | 35.35 on 06/22/26 | ||
| 1-Month | |||||
| %Chg | -24.22% since 05/22/26 | +0.47% since 05/22/26 | +21.11% since 05/22/26 | ||
| Low | 13.51 on 06/22/26 | 50.06 on 06/08/26 | 26.00 on 06/01/26 | ||
| High | 18.67 on 05/26/26 | 60.49 on 06/16/26 | 35.35 on 06/22/26 | ||
| 3-Month | |||||
| %Chg | +15.24% since 03/20/26 | +44.29% since 03/20/26 | +98.58% since 03/20/26 | ||
| Low | 10.14 on 04/07/26 | 36.15 on 04/01/26 | 16.50 on 03/30/26 | ||
| High | 18.92 on 05/11/26 | 72.36 on 05/05/26 | 35.35 on 06/22/26 | ||
| 6-Month | |||||
| %Chg | +1.26% since 12/22/25 | +78.79% since 12/22/25 | +48.39% since 12/22/25 | ||
| Low | 9.82 on 02/09/26 | 28.00 on 01/06/26 | 16.50 on 03/30/26 | ||
| High | 18.92 on 05/11/26 | 72.36 on 05/05/26 | 35.35 on 06/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,653,924 | 1,673,598 | 1,635,598 | ||
| Shares Outstanding, K | 115,821 | 29,101 | 48,722 | ||
| Annual Sales | 655,350,000 | 234,600,000 | 109,790,000 | ||
| Annual Net Income | -136,230,000 | -13,230,000 | -153,490,000 | ||
| Last Quarter Sales | 174,060,000 | 25,560,000 | 50,960,000 | ||
| Last Quarter Net Income | -71,140,000 | -52,880,000 | -23,570,000 | ||
| 60-Month Beta | 0.93 | 0.72 | 1.59 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.62 on 04/30/26 | -1.84 on 05/12/26 | -0.47 on 05/06/26 | ||
| Earnings Date | 07/23/26 | 08/05/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||